纽约市HIV感染者与COVID-19患者的COVID-19结局
本研究利用纽约市COVID-19监测和HIV监测系统数据,在COVID-19疫苗广泛可及之前开展回顾性队列研究,比较2020年2月29日至10月17日期间SARS-CoV-2诊断者中HIV感染者与非感染者的COVID-19住院和死亡风险。结果显示HIV感染者住院和死亡风险均较非感染者高近30%,CD4细胞计数和基础非HIV疾病与不良结局独立强相关。
要点
- HIV感染者COVID-19住院和死亡风险均较非感染者高近30%。
- 女性及黑人、西班牙裔/拉丁裔、美洲原住民和多种族人群中HIV感染者不良结局发生率升高。
- SARS-CoV-2诊断时CD4细胞计数和基础非HIV疾病与HIV感染者住院和死亡风险独立强相关。
核心结论
- 2020年期间纽约市HIV感染者较非感染者COVID-19不良结局风险升高。
- HIV感染者,尤其是CD4计数低或有基础疾病者,应持续作为COVID-19疫苗接种和SARS-CoV-2感染识别与治疗的重点对象。
研究设计与样本
- 利用纽约市COVID-19监测和HIV监测系统数据开展的回顾性队列研究。
- 比较2020年2月29日至10月17日期间SARS-CoV-2诊断者中HIV感染者与非感染者的COVID-19住院和死亡风险。
- 研究开展于COVID-19疫苗广泛可及之前。
主要发现
- HIV感染者COVID-19住院和死亡风险均较非感染者高近30%。
- 粗模型中,女性及黑人、西班牙裔/拉丁裔、美洲原住民和多种族人群中HIV感染者不良COVID-19结局发生率较非感染者升高。
- SARS-CoV-2诊断时CD4细胞计数和存在基础非HIV疾病与HIV感染者COVID-19住院和死亡风险独立且强相关。
临床怎么用
- 作者认为HIV感染者,尤其是CD4计数低或有基础疾病者,应持续作为COVID-19疫苗接种和SARS-CoV-2感染严格识别与治疗的重点对象以预防不良结局。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Literature on the impact of human immunodeficiency virus (HIV) on coronavirus disease 2019 (COVID-19)-related outcomes remains mixed. Few studies have evaluated COVID-19 outcomes by HIV status using population-based data. METHODS: Using data from New York City COVID-19 surveillance and HIV surveillance systems prior to the widespread availability of COVID-19 vaccines, we conducted a retrospective cohort study comparing the risk of COVID-19 hospitalization and mortality by HIV status among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diagnoses from 29 February to 17 October 2020. RESULTS: Risk of hospitalization and death among people with HIV (PWH) withCOVID-19 were both nearly 30% higher compared with people without HIV. In crude models, incidence of adverse COVID-19 outcomes among PWH compared to people without HIV was elevated in certain groups, including women, and black, Hispanic/Latino, Native American, and multiracial people. CD4 cell count at SARS-CoV-2 diagnosis and presence of an underlying, non-HIV-related condition were independently and strongly associated with risk for COVID-19 hospitalization and death among PWH. CONCLUSIONS: New Yorkers with HIV experienced elevated risk for poor COVID-19 outcomes compared to those without HIV during 2020. PWH, particularly those with low CD4 counts or underlying conditions, should be an ongoing focus for COVID-19 vaccination and rigorous identification and treatment of SARS-CoV-2 infections to prevent adverse outcomes.
引用
- Braunstein SL, Wahnich A, Lazar R, et al. COVID-19 Outcomes Among People With HIV and COVID-19 in New York City. J Infect Dis. 2023. PMID: 37534822. doi:10.1093/infdis/jiad311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。